{"result": "(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a medical condition characterized by excessive body fat that increases the risk of health problems, including cardiovascular disease and diabetes.)\n##\n(\"entity\"<|>METABOLIC SYNDROME<|>EVENT<|>Metabolic syndrome refers to a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, often associated with obesity.)\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension, or high blood pressure, is a condition that can lead to serious health issues, including heart disease and stroke, often seen in individuals with obesity.)\n##\n(\"entity\"<|>DISLIPIDEMIA<|>EVENT<|>Dyslipidemia is an abnormal amount of lipids in the blood, commonly associated with obesity and metabolic syndrome.)\n##\n(\"entity\"<|>NORMOPESO<|>EVENT<|>Normopeso refers to a healthy weight range, which is often used as a reference point in studies comparing health outcomes in different weight categories.)\n##\n(\"entity\"<|>GABA<|>EVENT<|>GABA (gamma-aminobutyric acid) is a neurotransmitter that plays a role in regulating neuronal excitability and is involved in appetite regulation.)\n##\n(\"relationship\"<|>OBESITY<|>METABOLIC SYNDROME<|>Obesity is a significant risk factor for developing metabolic syndrome, which includes various health complications.<|>9)\n##\n(\"relationship\"<|>OBESITY<|>HYPERTENSION<|>Obesity is associated with an increased risk of hypertension, contributing to cardiovascular disease.<|>8)\n##\n(\"relationship\"<|>OBESITY<|>DISLIPIDEMIA<|>Obesity often leads to dyslipidemia, which is characterized by abnormal lipid levels in the blood.<|>8)\n##\n(\"relationship\"<|>NORMOPESO<|>OBESITY<|>Normopeso serves as a reference point for defining obesity and assessing health risks associated with different weight categories.<|>6)\n##\n(\"relationship\"<|>GHRELIN<|>GABA<|>Ghrelin influences appetite through its action on GABAergic neurons in the hypothalamus, affecting hunger signals.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: “obesos metabólicamente normales” y los\n     rexígena, actuando principalmente en receptores de la vía anorexigénica. También inhibe                                                           “sujetos con normopeso metabólicamente enfermos” (con características a su homólogo\n     las señales de la vía del NPY, pero actuando a través del GABA (fig.                           2).                                                con obesidad). Estas diferencias radican en que los obesos que están “metabólicamente\n                                                                                                                                                       sanos” (aproximadamente un 20%), tienen menor porcentaje de grasa visceral, mayor dis-\n                                                                                                           La ghrelina tiene una acción orexígena      tribución de grasa periférica, no presentan comorbilidades metabólicas (dislipidemia atero-\n                                         Neurona                                                           actuando en el núcleo arcuato del\n                                                              Ingesta           Gasto                      hipotálamo sobre neuronas NPY/AGRP.\n                                                                                                           El resto de hormonas gastrointestinales     génica o resistencia a la insulina, hipertensión arterial), etc. De esta manera, los obesos sin\n                                                              alimentaria    energético                    tiene una acción anorexígena enviando\n                                                                                                           la información directamente por sangre      estas complicaciones tendrían un riesgo equivalente a los normopesos sanos.\n                                                                                        Núcleo             o por vía del vago a través del área\n                                                                                       arqueado            postrema, núcleo dorsal del vago y\n                                                                                                           finalmente el hipotálamo.\n                                                            Melanocortina     Receptor de MC4 (MC4R)                                                   Sin embargo, estudios epidemiológicos de cohortes han indicado que dicha relación es inexis-\n        Tercer               NPY/AGRP                                         (bloqueado por AGRP)\n      ventrículo                                                              Receptor de ghrelina                                                     tente. Es una cuestión de tiempo que los obesos metabólicamente sanos cambien su tipolo-\n                                                                              Receptor YR2 de NPY/PYY3-36                                              gía hacia una variante menos sana. Los obesos aun sin comorbilidades tienen un incremento\n                     Ghrelina                                                 Receptor de MC 3 (MC3R)                                                  del riesgo de enfermedad coronaria (49%), de ictus                        (9%) o de insuficiencia cardíaca (96%)\n                                                                              Receptor de YR1 NPY                                                      respecto a los individuos con normopeso sanos.\n            PYY 3-36                                      Insulina            Receptor de leptina o receptor\n                                Estómago   Leptina                            de insulina\n                                                                                                                                                       En el estudio de cohortes de las enfermeras americanas (Nurses’ Health Study), que eng-\n                                                                          Páncreas                                                                     loba a más de 90.000 mujeres seguidas durante 30 años, el 84% de las mujeres                                      obesas\n                                Colón    Tejido adiposo                                                                                                metabólicamente sanas (y también el 68% de las que tenían normopeso) cambiaron a un\n                                distal\n                                                                                                                                                       fenotipo menos saludable tras 20 años de seguimiento. Incluso aquellas mujeres que se\n     Figura 2. Regulación del control homeostático del peso.                                                                                           mantuvieron con una obesidad metabólicamente sana tenían un mayor riesgo (hazard ratio\n     Modificado de: Schwartz MW, Morton GJ. Obesity: keeping hunger at bay. Nature. 2002;418(6898):595-7.                                              [HR]:   1,57; intervalo de confianza al            95% [IC 95%]:       1,03-2,38), de tener una enfermedad car-\n                                                                                                                                                       diovascular que las mujeres sanas con normopeso.\n     El péptido YY, al igual que el GLP-1, se secreta en el intestino distal y su acción principal es\n     anorexígena,       pero actuando sobre las neuronas del NPY, aunque en otro receptor diferente                                                    En el estudio de cohortes realizado en el European Prospective Investigation into Cancer\n     de los cinco posibles.         En concreto, interaccionando con el receptor NPY-2R.                                                               and Nutrition study (EPIC-CVD), durante un seguimiento medio de 12,2 años, se establecie-\n                                                                                                                                                       ron los HR de enfermedad coronaria en diferentes tipologías de peso corporal. Comparado\n     Referencias:                                                                                                                                      con normopeso saludable (referencia),                   los HR fueron 2,15 (IC 95%: 1,79-2,57) para “normo-\n     • Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117(1):13-23.\n     • Guyenet SJ, Schwartz MW. Regulation of Food Intake, Energy Balance, and Body Fat Mass: Implications for the Pathogenesis and Treat-             peso     no  saludable”;      2,33 (IC 95%:1,97-2,76) para             sobrepeso no saludable y 2,54 (IC 95%:\n       ment of Obesity. J Clin Endocrinol Metab. 2012;97:745-55.                                                                                       2,\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>GHRELIN<|>EVENT<|>Ghrelin is a hormone that has orexigenic action, influencing appetite regulation in the hypothalamus.)\n##\n(\"entity\"<|>PEPTIDE YY<|>EVENT<|>Peptide YY is a hormone secreted in the distal intestine that primarily has anorexigenic effects.)\n##\n(\"entity\"<|>NURSES' HEALTH STUDY<|>EVENT<|>The Nurses' Health Study is a long-term epidemiological study involving over 90,000 women, tracking health outcomes over 30 years.)\n##\n(\"entity\"<|>EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION STUDY<|>EVENT<|>The EPIC study is a cohort study that investigates the relationship between diet, lifestyle, and health outcomes in Europe.)\n##\n(\"entity\"<|>SCHWARTZ MW<|>PERSON<|>Schwartz MW is a researcher who has contributed to the understanding of obesity and appetite regulation.)\n##\n(\"entity\"<|>CUMMINGS DE<|>PERSON<|>Cummings DE is a researcher known for work on gastrointestinal regulation of food intake.)\n##\n(\"relationship\"<|>GHRELIN<|>PEPTIDE YY<|>Both ghrelin and peptide YY are hormones involved in the regulation of appetite, with opposing effects on hunger.<|>7)\n##\n(\"relationship\"<|>NURSES' HEALTH STUDY<|>EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION STUDY<|>Both studies investigate health outcomes related to obesity and metabolic health over long periods.<|>6)\n##\n(\"relationship\"<|>SCHWARTZ MW<|>CUMMINGS DE<|>Both Schwartz MW and Cummings DE are researchers who have published work on the regulation of food intake and obesity.<|>8)\n<|COMPLETE|>"}]}